Key result
Submaximal CPET offers prognostic value in cardiac amyloidosis as an alternative to the 6MWT.
Why the study?
Does submaximal cardiopulmonary exercise testing (CPET) provide prognostic value and serve as an alternative to the 6-min walk test in patients with cardiac amyloidosis?
Does submaximal cardiopulmonary exercise testing (CPET) provide prognostic value and serve as an alternative to the 6-min walk test in patients with cardiac amyloidosis?
Submaximal cardiopulmonary exercise testing (CPET) is being explored for its prognostic value and as an alternative to the 6-min walk test in cardiac amyloidosis.
May refine prognostication in cardiac amyloidosis; hypothesis-generating and requires validation before 6-min walk test replacement.
Background: This study assessed the prognostic value of submaximal cardiopulmonary exercise testing (CPET) in cardiac amyloidosis and explored CPET as an alternative to the 6-min walk test (6MWT).
No takes yet. Share an insight, caveat, or question.
Willixhofer et al. (2025) studied this question. Submaximal CPET provides valuable prognostic information in cardiac amyloidosis and may serve as an alternative to the 6-min walk test.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: